look news india
Last week, shares of Deepna Pharmachem Limited remained a topic of discussion among investors. On Friday, shares of this company jumped by 10% and touched an intra-day high of Rs 11.91. In just five days, the stock has gained nearly 65%, taking it from the Rs 7 level to its current price.
Current stock status and performance
Shares of Dipna Pharmachem Limited have shown a rise of 47% in the last six months. Within a month it has seen a rise of 75%, whereas so far this year its price has increased by 32%. However, the stock has declined 54% in the last five years.
- 52-week high price: Rs 14.53
- 52-week low price: Rs 6.40
- Market cap: Rs 28.64 crore
It is noteworthy that the company launched its IPO on the BSE SME platform in August 2022. The price band of this IPO was Rs 38, with a market lot of 3000 shares being offered. This year, shares of Dipna Pharmachem traded in ex-bonus and ex-split mode, leading to sharp fluctuations in its prices.
Company business information
Deepna Pharmachem Limited was established in 2011 and is engaged in the field of Industrial Chemicals, Pharmaceutical Raw Materials, APIs (Active Pharmaceutical Ingredients), Solvents, and Formulations. The company has made its mark globally as a trader, importer and exporter.
The company is primarily identified by its quality and innovative services provided to its customers. Demand for its products is increasing globally, and its business is expanding rapidly.
Penny Stocks: Risks and Prospects
Penny stocks are shares of small-sized companies that typically trade at low prices. Investing in these stocks is risky due to high volatility and low liquidity. However, when invested at the right time, these stocks can also give good profits.
Is Deepna Pharmachem good for investment?
The performance of Dipna Pharmachem Limited shares has been attractive in recent times, but being a penny stock, it is important to assess the risks before investing in it. Studying market trends, company balance sheet, and upcoming growth plans will help investors take informed decisions.
